Potential issues may include: Underdosed products Poor peptide quality Inconsistent administration Protocols that are too short Concentrations that are too low for the severity of the condition In many situations, the issue may not be that peptides do not work, but rather that the body is not receiving adequate and consistent support for long enough
When we fragment the body into specialties, we miss the interconnections that drive both dysfunction and healing
What types of infusion therapy are used to treat ulcerative colitis
Third, consider your study's endpoint
Here is the breakdown: There is an important caveat
the catheters were flushed with heparinized saline before and after blood sample collection and filled with heparin-glycerol locking solution (6 mL glycerol, 3 mL saline, 0.5 mL gentamycin (lOOmg/mL), 0.5 mL heparin (10,000 u/mL)) when not used for more than 8 h